nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—ABCC1—Vandetanib—thyroid cancer	0.138	0.169	CbGbCtD
Rosuvastatin—ABCC4—Sorafenib—thyroid cancer	0.104	0.126	CbGbCtD
Rosuvastatin—ABCC1—Epirubicin—thyroid cancer	0.0952	0.116	CbGbCtD
Rosuvastatin—ABCG2—Vandetanib—thyroid cancer	0.0926	0.113	CbGbCtD
Rosuvastatin—ABCB11—Doxorubicin—thyroid cancer	0.0712	0.0868	CbGbCtD
Rosuvastatin—ALB—Vandetanib—thyroid cancer	0.0638	0.0777	CbGbCtD
Rosuvastatin—ABCG2—Sorafenib—thyroid cancer	0.0558	0.068	CbGbCtD
Rosuvastatin—ABCC1—Doxorubicin—thyroid cancer	0.0506	0.0616	CbGbCtD
Rosuvastatin—ABCG2—Doxorubicin—thyroid cancer	0.0339	0.0412	CbGbCtD
Rosuvastatin—CYP3A5—Sorafenib—thyroid cancer	0.0309	0.0377	CbGbCtD
Rosuvastatin—CYP2C19—Sorafenib—thyroid cancer	0.0249	0.0304	CbGbCtD
Rosuvastatin—CYP2C9—Sorafenib—thyroid cancer	0.0207	0.0253	CbGbCtD
Rosuvastatin—CYP3A4—Vandetanib—thyroid cancer	0.02	0.0244	CbGbCtD
Rosuvastatin—CYP3A4—Sorafenib—thyroid cancer	0.0121	0.0147	CbGbCtD
Rosuvastatin—Musculoskeletal disorder—Vandetanib—thyroid cancer	0.00766	0.0637	CcSEcCtD
Rosuvastatin—CYP3A4—Doxorubicin—thyroid cancer	0.00732	0.00891	CbGbCtD
Rosuvastatin—Nephropathy—Vandetanib—thyroid cancer	0.00575	0.0478	CcSEcCtD
Rosuvastatin—Proteinuria—Vandetanib—thyroid cancer	0.00311	0.0259	CcSEcCtD
Rosuvastatin—Protein urine present—Vandetanib—thyroid cancer	0.00307	0.0255	CcSEcCtD
Rosuvastatin—Gastroenteritis—Vandetanib—thyroid cancer	0.00224	0.0186	CcSEcCtD
Rosuvastatin—Proteinuria—Sorafenib—thyroid cancer	0.0021	0.0175	CcSEcCtD
Rosuvastatin—Rhabdomyolysis—Sorafenib—thyroid cancer	0.00209	0.0173	CcSEcCtD
Rosuvastatin—Protein urine present—Sorafenib—thyroid cancer	0.00207	0.0172	CcSEcCtD
Rosuvastatin—Drug interaction—Sorafenib—thyroid cancer	0.00199	0.0165	CcSEcCtD
Rosuvastatin—Influenza—Vandetanib—thyroid cancer	0.00172	0.0143	CcSEcCtD
Rosuvastatin—Pancreatitis—Vandetanib—thyroid cancer	0.00168	0.014	CcSEcCtD
Rosuvastatin—Gynaecomastia—Sorafenib—thyroid cancer	0.00165	0.0137	CcSEcCtD
Rosuvastatin—Bronchitis—Vandetanib—thyroid cancer	0.00165	0.0137	CcSEcCtD
Rosuvastatin—Depression—Vandetanib—thyroid cancer	0.00153	0.0127	CcSEcCtD
Rosuvastatin—Hepatic failure—Sorafenib—thyroid cancer	0.00149	0.0124	CcSEcCtD
Rosuvastatin—Urinary tract infection—Vandetanib—thyroid cancer	0.00149	0.0124	CcSEcCtD
Rosuvastatin—Haematuria—Vandetanib—thyroid cancer	0.00146	0.0121	CcSEcCtD
Rosuvastatin—Renal failure acute—Sorafenib—thyroid cancer	0.00145	0.0121	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00145	0.012	CcSEcCtD
Rosuvastatin—Sinusitis—Vandetanib—thyroid cancer	0.00144	0.0119	CcSEcCtD
Rosuvastatin—Myositis—Epirubicin—thyroid cancer	0.00139	0.0116	CcSEcCtD
Rosuvastatin—Myositis—Doxorubicin—thyroid cancer	0.00129	0.0107	CcSEcCtD
Rosuvastatin—Arrhythmia—Vandetanib—thyroid cancer	0.00123	0.0102	CcSEcCtD
Rosuvastatin—Breast disorder—Sorafenib—thyroid cancer	0.00121	0.0101	CcSEcCtD
Rosuvastatin—Mental disorder—Vandetanib—thyroid cancer	0.0012	0.01	CcSEcCtD
Rosuvastatin—Urine analysis abnormal—Epirubicin—thyroid cancer	0.00116	0.00964	CcSEcCtD
Rosuvastatin—Pancreatitis—Sorafenib—thyroid cancer	0.00114	0.00944	CcSEcCtD
Rosuvastatin—Urine analysis abnormal—Doxorubicin—thyroid cancer	0.00107	0.00892	CcSEcCtD
Rosuvastatin—Cough—Vandetanib—thyroid cancer	0.00104	0.00868	CcSEcCtD
Rosuvastatin—Arthralgia—Vandetanib—thyroid cancer	0.00102	0.00846	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00101	0.00841	CcSEcCtD
Rosuvastatin—Jaundice—Sorafenib—thyroid cancer	0.00101	0.00836	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000976	0.00812	CcSEcCtD
Rosuvastatin—Infection—Vandetanib—thyroid cancer	0.00097	0.00806	CcSEcCtD
Rosuvastatin—Nervous system disorder—Vandetanib—thyroid cancer	0.000957	0.00796	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Vandetanib—thyroid cancer	0.000956	0.00794	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000889	0.00739	CcSEcCtD
Rosuvastatin—Insomnia—Vandetanib—thyroid cancer	0.000883	0.00734	CcSEcCtD
Rosuvastatin—Paraesthesia—Vandetanib—thyroid cancer	0.000876	0.00729	CcSEcCtD
Rosuvastatin—Dyspepsia—Vandetanib—thyroid cancer	0.000859	0.00714	CcSEcCtD
Rosuvastatin—Constipation—Vandetanib—thyroid cancer	0.000835	0.00694	CcSEcCtD
Rosuvastatin—Pain—Vandetanib—thyroid cancer	0.000835	0.00694	CcSEcCtD
Rosuvastatin—Arrhythmia—Sorafenib—thyroid cancer	0.000828	0.00688	CcSEcCtD
Rosuvastatin—Blood disorder—Epirubicin—thyroid cancer	0.000817	0.00679	CcSEcCtD
Rosuvastatin—Mental disorder—Sorafenib—thyroid cancer	0.000812	0.00675	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000798	0.00663	CcSEcCtD
Rosuvastatin—Abdominal pain—Vandetanib—thyroid cancer	0.000772	0.00641	CcSEcCtD
Rosuvastatin—Blood disorder—Doxorubicin—thyroid cancer	0.000756	0.00628	CcSEcCtD
Rosuvastatin—Cough increased—Epirubicin—thyroid cancer	0.000745	0.00619	CcSEcCtD
Rosuvastatin—Angioedema—Sorafenib—thyroid cancer	0.000737	0.00613	CcSEcCtD
Rosuvastatin—Cough—Sorafenib—thyroid cancer	0.000704	0.00585	CcSEcCtD
Rosuvastatin—Asthenia—Vandetanib—thyroid cancer	0.0007	0.00582	CcSEcCtD
Rosuvastatin—Pruritus—Vandetanib—thyroid cancer	0.000691	0.00574	CcSEcCtD
Rosuvastatin—Cough increased—Doxorubicin—thyroid cancer	0.000689	0.00573	CcSEcCtD
Rosuvastatin—Myalgia—Sorafenib—thyroid cancer	0.000687	0.00571	CcSEcCtD
Rosuvastatin—Arthralgia—Sorafenib—thyroid cancer	0.000687	0.00571	CcSEcCtD
Rosuvastatin—Diarrhoea—Vandetanib—thyroid cancer	0.000668	0.00555	CcSEcCtD
Rosuvastatin—Infection—Sorafenib—thyroid cancer	0.000654	0.00544	CcSEcCtD
Rosuvastatin—Nervous system disorder—Sorafenib—thyroid cancer	0.000646	0.00537	CcSEcCtD
Rosuvastatin—Dizziness—Vandetanib—thyroid cancer	0.000645	0.00537	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000645	0.00536	CcSEcCtD
Rosuvastatin—Rash—Vandetanib—thyroid cancer	0.000615	0.00512	CcSEcCtD
Rosuvastatin—Dermatitis—Vandetanib—thyroid cancer	0.000615	0.00511	CcSEcCtD
Rosuvastatin—Headache—Vandetanib—thyroid cancer	0.000611	0.00508	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0006	0.00499	CcSEcCtD
Rosuvastatin—Hypertonia—Epirubicin—thyroid cancer	0.000598	0.00497	CcSEcCtD
Rosuvastatin—Nausea—Vandetanib—thyroid cancer	0.00058	0.00482	CcSEcCtD
Rosuvastatin—Dyspepsia—Sorafenib—thyroid cancer	0.00058	0.00482	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Epirubicin—thyroid cancer	0.000569	0.00473	CcSEcCtD
Rosuvastatin—Pain—Sorafenib—thyroid cancer	0.000563	0.00468	CcSEcCtD
Rosuvastatin—Constipation—Sorafenib—thyroid cancer	0.000563	0.00468	CcSEcCtD
Rosuvastatin—Hypertonia—Doxorubicin—thyroid cancer	0.000553	0.0046	CcSEcCtD
Rosuvastatin—Hepatic failure—Epirubicin—thyroid cancer	0.000551	0.00458	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000538	0.00448	CcSEcCtD
Rosuvastatin—Renal failure acute—Epirubicin—thyroid cancer	0.000536	0.00446	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000527	0.00438	CcSEcCtD
Rosuvastatin—Urticaria—Sorafenib—thyroid cancer	0.000523	0.00435	CcSEcCtD
Rosuvastatin—Abdominal pain—Sorafenib—thyroid cancer	0.00052	0.00433	CcSEcCtD
Rosuvastatin—Hepatic failure—Doxorubicin—thyroid cancer	0.00051	0.00424	CcSEcCtD
Rosuvastatin—Renal failure acute—Doxorubicin—thyroid cancer	0.000496	0.00412	CcSEcCtD
Rosuvastatin—Hypersensitivity—Sorafenib—thyroid cancer	0.000485	0.00403	CcSEcCtD
Rosuvastatin—Asthenia—Sorafenib—thyroid cancer	0.000472	0.00393	CcSEcCtD
Rosuvastatin—Pruritus—Sorafenib—thyroid cancer	0.000466	0.00387	CcSEcCtD
Rosuvastatin—Diarrhoea—Sorafenib—thyroid cancer	0.00045	0.00374	CcSEcCtD
Rosuvastatin—Breast disorder—Epirubicin—thyroid cancer	0.000447	0.00372	CcSEcCtD
Rosuvastatin—Muscular weakness—Epirubicin—thyroid cancer	0.000437	0.00363	CcSEcCtD
Rosuvastatin—Dizziness—Sorafenib—thyroid cancer	0.000435	0.00362	CcSEcCtD
Rosuvastatin—Influenza—Epirubicin—thyroid cancer	0.000428	0.00356	CcSEcCtD
Rosuvastatin—Pancreatitis—Epirubicin—thyroid cancer	0.00042	0.00349	CcSEcCtD
Rosuvastatin—Rash—Sorafenib—thyroid cancer	0.000415	0.00345	CcSEcCtD
Rosuvastatin—Dermatitis—Sorafenib—thyroid cancer	0.000415	0.00345	CcSEcCtD
Rosuvastatin—Breast disorder—Doxorubicin—thyroid cancer	0.000414	0.00344	CcSEcCtD
Rosuvastatin—Headache—Sorafenib—thyroid cancer	0.000412	0.00343	CcSEcCtD
Rosuvastatin—Bronchitis—Epirubicin—thyroid cancer	0.000412	0.00342	CcSEcCtD
Rosuvastatin—HMGCR—neck—thyroid cancer	0.000411	0.109	CbGeAlD
Rosuvastatin—Muscular weakness—Doxorubicin—thyroid cancer	0.000404	0.00336	CcSEcCtD
Rosuvastatin—Influenza—Doxorubicin—thyroid cancer	0.000396	0.00329	CcSEcCtD
Rosuvastatin—Nausea—Sorafenib—thyroid cancer	0.000391	0.00325	CcSEcCtD
Rosuvastatin—Pancreatitis—Doxorubicin—thyroid cancer	0.000388	0.00323	CcSEcCtD
Rosuvastatin—Bronchitis—Doxorubicin—thyroid cancer	0.000381	0.00317	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000374	0.00311	CcSEcCtD
Rosuvastatin—Jaundice—Epirubicin—thyroid cancer	0.000372	0.00309	CcSEcCtD
Rosuvastatin—Urinary tract infection—Epirubicin—thyroid cancer	0.000371	0.00308	CcSEcCtD
Rosuvastatin—Haematuria—Epirubicin—thyroid cancer	0.000364	0.00302	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000361	0.003	CcSEcCtD
Rosuvastatin—Sinusitis—Epirubicin—thyroid cancer	0.000358	0.00298	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000346	0.00288	CcSEcCtD
Rosuvastatin—Jaundice—Doxorubicin—thyroid cancer	0.000344	0.00286	CcSEcCtD
Rosuvastatin—Rhinitis—Epirubicin—thyroid cancer	0.000343	0.00285	CcSEcCtD
Rosuvastatin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000343	0.00285	CcSEcCtD
Rosuvastatin—Hepatitis—Epirubicin—thyroid cancer	0.000343	0.00285	CcSEcCtD
Rosuvastatin—Pharyngitis—Epirubicin—thyroid cancer	0.00034	0.00283	CcSEcCtD
Rosuvastatin—Haematuria—Doxorubicin—thyroid cancer	0.000337	0.0028	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000334	0.00278	CcSEcCtD
Rosuvastatin—Sinusitis—Doxorubicin—thyroid cancer	0.000331	0.00275	CcSEcCtD
Rosuvastatin—HMGCR—saliva-secreting gland—thyroid cancer	0.000321	0.0849	CbGeAlD
Rosuvastatin—Rhinitis—Doxorubicin—thyroid cancer	0.000318	0.00264	CcSEcCtD
Rosuvastatin—Hepatitis—Doxorubicin—thyroid cancer	0.000317	0.00263	CcSEcCtD
Rosuvastatin—SLC7A11—thyroid gland—thyroid cancer	0.000315	0.0833	CbGeAlD
Rosuvastatin—Pharyngitis—Doxorubicin—thyroid cancer	0.000315	0.00261	CcSEcCtD
Rosuvastatin—Arrhythmia—Epirubicin—thyroid cancer	0.000306	0.00254	CcSEcCtD
Rosuvastatin—Mental disorder—Epirubicin—thyroid cancer	0.0003	0.00249	CcSEcCtD
Rosuvastatin—Flatulence—Epirubicin—thyroid cancer	0.000294	0.00244	CcSEcCtD
Rosuvastatin—Arrhythmia—Doxorubicin—thyroid cancer	0.000283	0.00235	CcSEcCtD
Rosuvastatin—SLC7A11—head—thyroid cancer	0.000279	0.0739	CbGeAlD
Rosuvastatin—Mental disorder—Doxorubicin—thyroid cancer	0.000278	0.00231	CcSEcCtD
Rosuvastatin—Flatulence—Doxorubicin—thyroid cancer	0.000272	0.00226	CcSEcCtD
Rosuvastatin—Cough—Epirubicin—thyroid cancer	0.00026	0.00216	CcSEcCtD
Rosuvastatin—Arthralgia—Epirubicin—thyroid cancer	0.000254	0.00211	CcSEcCtD
Rosuvastatin—Myalgia—Epirubicin—thyroid cancer	0.000254	0.00211	CcSEcCtD
Rosuvastatin—HMGCR—trachea—thyroid cancer	0.000247	0.0655	CbGeAlD
Rosuvastatin—Confusional state—Epirubicin—thyroid cancer	0.000245	0.00204	CcSEcCtD
Rosuvastatin—Infection—Epirubicin—thyroid cancer	0.000242	0.00201	CcSEcCtD
Rosuvastatin—Cough—Doxorubicin—thyroid cancer	0.000241	0.002	CcSEcCtD
Rosuvastatin—Nervous system disorder—Epirubicin—thyroid cancer	0.000239	0.00198	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000238	0.00198	CcSEcCtD
Rosuvastatin—Arthralgia—Doxorubicin—thyroid cancer	0.000235	0.00195	CcSEcCtD
Rosuvastatin—Myalgia—Doxorubicin—thyroid cancer	0.000235	0.00195	CcSEcCtD
Rosuvastatin—Confusional state—Doxorubicin—thyroid cancer	0.000227	0.00189	CcSEcCtD
Rosuvastatin—Infection—Doxorubicin—thyroid cancer	0.000224	0.00186	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000222	0.00184	CcSEcCtD
Rosuvastatin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000221	0.00184	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00022	0.00183	CcSEcCtD
Rosuvastatin—Insomnia—Epirubicin—thyroid cancer	0.00022	0.00183	CcSEcCtD
Rosuvastatin—Paraesthesia—Epirubicin—thyroid cancer	0.000218	0.00182	CcSEcCtD
Rosuvastatin—Dyspepsia—Epirubicin—thyroid cancer	0.000214	0.00178	CcSEcCtD
Rosuvastatin—Pain—Epirubicin—thyroid cancer	0.000208	0.00173	CcSEcCtD
Rosuvastatin—Constipation—Epirubicin—thyroid cancer	0.000208	0.00173	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000205	0.00171	CcSEcCtD
Rosuvastatin—Insomnia—Doxorubicin—thyroid cancer	0.000204	0.00169	CcSEcCtD
Rosuvastatin—Paraesthesia—Doxorubicin—thyroid cancer	0.000202	0.00168	CcSEcCtD
Rosuvastatin—Feeling abnormal—Epirubicin—thyroid cancer	0.000201	0.00167	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000199	0.00165	CcSEcCtD
Rosuvastatin—Dyspepsia—Doxorubicin—thyroid cancer	0.000198	0.00165	CcSEcCtD
Rosuvastatin—HMGCR—thyroid gland—thyroid cancer	0.000196	0.0518	CbGeAlD
Rosuvastatin—Urticaria—Epirubicin—thyroid cancer	0.000193	0.00161	CcSEcCtD
Rosuvastatin—Pain—Doxorubicin—thyroid cancer	0.000193	0.0016	CcSEcCtD
Rosuvastatin—Constipation—Doxorubicin—thyroid cancer	0.000193	0.0016	CcSEcCtD
Rosuvastatin—Abdominal pain—Epirubicin—thyroid cancer	0.000192	0.0016	CcSEcCtD
Rosuvastatin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000186	0.00154	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000184	0.00153	CcSEcCtD
Rosuvastatin—Hypersensitivity—Epirubicin—thyroid cancer	0.000179	0.00149	CcSEcCtD
Rosuvastatin—Urticaria—Doxorubicin—thyroid cancer	0.000179	0.00149	CcSEcCtD
Rosuvastatin—Abdominal pain—Doxorubicin—thyroid cancer	0.000178	0.00148	CcSEcCtD
Rosuvastatin—Asthenia—Epirubicin—thyroid cancer	0.000175	0.00145	CcSEcCtD
Rosuvastatin—HMGCR—head—thyroid cancer	0.000174	0.046	CbGeAlD
Rosuvastatin—Pruritus—Epirubicin—thyroid cancer	0.000172	0.00143	CcSEcCtD
Rosuvastatin—ABCG2—saliva-secreting gland—thyroid cancer	0.00017	0.045	CbGeAlD
Rosuvastatin—Diarrhoea—Epirubicin—thyroid cancer	0.000166	0.00138	CcSEcCtD
Rosuvastatin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000166	0.00138	CcSEcCtD
Rosuvastatin—SLCO2B1—thyroid gland—thyroid cancer	0.000166	0.0439	CbGeAlD
Rosuvastatin—Asthenia—Doxorubicin—thyroid cancer	0.000162	0.00134	CcSEcCtD
Rosuvastatin—Dizziness—Epirubicin—thyroid cancer	0.000161	0.00134	CcSEcCtD
Rosuvastatin—Pruritus—Doxorubicin—thyroid cancer	0.000159	0.00132	CcSEcCtD
Rosuvastatin—ABCC1—trachea—thyroid cancer	0.000158	0.0419	CbGeAlD
Rosuvastatin—Diarrhoea—Doxorubicin—thyroid cancer	0.000154	0.00128	CcSEcCtD
Rosuvastatin—Rash—Epirubicin—thyroid cancer	0.000153	0.00128	CcSEcCtD
Rosuvastatin—Dermatitis—Epirubicin—thyroid cancer	0.000153	0.00127	CcSEcCtD
Rosuvastatin—Headache—Epirubicin—thyroid cancer	0.000152	0.00127	CcSEcCtD
Rosuvastatin—Dizziness—Doxorubicin—thyroid cancer	0.000149	0.00124	CcSEcCtD
Rosuvastatin—SLCO2B1—head—thyroid cancer	0.000147	0.0389	CbGeAlD
Rosuvastatin—ABCC4—thyroid gland—thyroid cancer	0.000147	0.0389	CbGeAlD
Rosuvastatin—Nausea—Epirubicin—thyroid cancer	0.000145	0.0012	CcSEcCtD
Rosuvastatin—Rash—Doxorubicin—thyroid cancer	0.000142	0.00118	CcSEcCtD
Rosuvastatin—Dermatitis—Doxorubicin—thyroid cancer	0.000142	0.00118	CcSEcCtD
Rosuvastatin—Headache—Doxorubicin—thyroid cancer	0.000141	0.00117	CcSEcCtD
Rosuvastatin—SLCO1A2—head—thyroid cancer	0.000135	0.0358	CbGeAlD
Rosuvastatin—Nausea—Doxorubicin—thyroid cancer	0.000134	0.00111	CcSEcCtD
Rosuvastatin—ABCC4—head—thyroid cancer	0.00013	0.0345	CbGeAlD
Rosuvastatin—ABCC1—thyroid gland—thyroid cancer	0.000125	0.0331	CbGeAlD
Rosuvastatin—HMGCR—lymph node—thyroid cancer	0.000122	0.0322	CbGeAlD
Rosuvastatin—ABCG2—thyroid gland—thyroid cancer	0.000104	0.0274	CbGeAlD
Rosuvastatin—SLCO2B1—lymph node—thyroid cancer	0.000103	0.0273	CbGeAlD
Rosuvastatin—ABCC1—Disease—TRIM33—thyroid cancer	9.75e-05	0.00178	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.7e-05	0.00177	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CHST14—thyroid cancer	9.58e-05	0.00174	CbGpPWpGaD
Rosuvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.54e-05	0.00174	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—MINPP1—thyroid cancer	9.48e-05	0.00173	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	9.46e-05	0.00172	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	9.46e-05	0.00172	CbGpPWpGaD
Rosuvastatin—ALB—lymph node—thyroid cancer	9.42e-05	0.0249	CbGeAlD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.31e-05	0.0017	CbGpPWpGaD
Rosuvastatin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	9.25e-05	0.00169	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—HPGD—thyroid cancer	9.25e-05	0.00168	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—NDUFA13—thyroid cancer	9.16e-05	0.00167	CbGpPWpGaD
Rosuvastatin—ABCC4—lymph node—thyroid cancer	9.12e-05	0.0241	CbGeAlD
Rosuvastatin—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	9.1e-05	0.00166	CbGpPWpGaD
Rosuvastatin—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	9.1e-05	0.00166	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.02e-05	0.00164	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	8.86e-05	0.00161	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	8.71e-05	0.00159	CbGpPWpGaD
Rosuvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.7e-05	0.00159	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CHST14—thyroid cancer	8.62e-05	0.00157	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	8.52e-05	0.00155	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.52e-05	0.00155	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.47e-05	0.00154	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.38e-05	0.00153	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CHST14—thyroid cancer	8.19e-05	0.00149	CbGpPWpGaD
Rosuvastatin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.1e-05	0.00148	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.09e-05	0.00147	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	8.09e-05	0.00147	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—NDUFA13—thyroid cancer	8.06e-05	0.00147	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.97e-05	0.00145	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.96e-05	0.00145	CbGpPWpGaD
Rosuvastatin—ABCC1—lymph node—thyroid cancer	7.78e-05	0.0206	CbGeAlD
Rosuvastatin—SLCO1A2—Metabolism—HPGD—thyroid cancer	7.72e-05	0.00141	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—IFNA2—thyroid cancer	7.69e-05	0.0014	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.65e-05	0.00139	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.6e-05	0.00139	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CHST14—thyroid cancer	7.58e-05	0.00138	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.58e-05	0.00138	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.5e-05	0.00137	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	7.49e-05	0.00137	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	7.49e-05	0.00137	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	7.48e-05	0.00136	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.37e-05	0.00134	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—TPR—thyroid cancer	7.34e-05	0.00134	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PRKAR1A—thyroid cancer	7.23e-05	0.00132	CbGpPWpGaD
Rosuvastatin—CYP2C19—Biological oxidations—RXRA—thyroid cancer	7.15e-05	0.0013	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.09e-05	0.00129	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—HPGD—thyroid cancer	6.95e-05	0.00127	CbGpPWpGaD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.93e-05	0.00126	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.93e-05	0.00126	CbGpPWpGaD
Rosuvastatin—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	6.81e-05	0.00124	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—MINPP1—thyroid cancer	6.8e-05	0.00124	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	6.76e-05	0.00123	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—HPGD—thyroid cancer	6.6e-05	0.0012	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.55e-05	0.00119	CbGpPWpGaD
Rosuvastatin—CYP2C9—Biological oxidations—RXRA—thyroid cancer	6.52e-05	0.00119	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TCF7L1—thyroid cancer	6.51e-05	0.00119	CbGpPWpGaD
Rosuvastatin—ABCG2—lymph node—thyroid cancer	6.44e-05	0.017	CbGeAlD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.43e-05	0.00117	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.38e-05	0.00116	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.26e-05	0.00114	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—HPGD—thyroid cancer	6.11e-05	0.00111	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.06e-05	0.0011	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.95e-05	0.00108	CbGpPWpGaD
Rosuvastatin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	5.92e-05	0.00108	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—MINPP1—thyroid cancer	5.85e-05	0.00107	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—NRAS—thyroid cancer	5.81e-05	0.00106	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	5.78e-05	0.00105	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—TPR—thyroid cancer	5.64e-05	0.00103	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.63e-05	0.00103	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.61e-05	0.00102	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	5.55e-05	0.00101	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—SLC5A5—thyroid cancer	5.5e-05	0.001	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CHST14—thyroid cancer	5.43e-05	0.00099	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.36e-05	0.000976	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.35e-05	0.000976	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—TPR—thyroid cancer	5.31e-05	0.000968	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PRKAR1A—thyroid cancer	5.26e-05	0.000958	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—MINPP1—thyroid cancer	5.25e-05	0.000957	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PRKAR1A—thyroid cancer	5.22e-05	0.000952	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.15e-05	0.000939	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.09e-05	0.000928	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—TP53—thyroid cancer	5.07e-05	0.000923	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.03e-05	0.000917	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—KRAS—thyroid cancer	5e-05	0.000911	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NDUFA13—thyroid cancer	4.98e-05	0.000907	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.79e-05	0.000873	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TPR—thyroid cancer	4.76e-05	0.000868	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.73e-05	0.000863	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.71e-05	0.000859	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PRKAR1A—thyroid cancer	4.69e-05	0.000854	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CHST14—thyroid cancer	4.68e-05	0.000852	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	4.62e-05	0.000843	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	4.62e-05	0.000843	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—RXRA—thyroid cancer	4.62e-05	0.000842	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.55e-05	0.000829	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.49e-05	0.000819	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MEN1—thyroid cancer	4.48e-05	0.000816	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NDUFA13—thyroid cancer	4.47e-05	0.000814	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—TP53—thyroid cancer	4.44e-05	0.00081	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—TPR—thyroid cancer	4.43e-05	0.000808	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—HPGD—thyroid cancer	4.38e-05	0.000798	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	4.36e-05	0.000795	CbGpPWpGaD
Rosuvastatin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.3e-05	0.000784	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—HRAS—thyroid cancer	4.25e-05	0.000774	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	4.22e-05	0.00077	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CHST14—thyroid cancer	4.2e-05	0.000765	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	4.07e-05	0.000742	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—TPR—thyroid cancer	3.99e-05	0.000727	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—SLC5A5—thyroid cancer	3.98e-05	0.000724	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.96e-05	0.000721	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.95e-05	0.00072	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PRKAR1A—thyroid cancer	3.92e-05	0.000715	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CHST14—thyroid cancer	3.83e-05	0.000698	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—TPR—thyroid cancer	3.79e-05	0.000691	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—HPGD—thyroid cancer	3.77e-05	0.000687	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—AKT1—thyroid cancer	3.75e-05	0.000684	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	3.73e-05	0.00068	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.72e-05	0.000679	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	3.6e-05	0.000655	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CALCA—thyroid cancer	3.57e-05	0.00065	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.56e-05	0.000648	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—RXRA—thyroid cancer	3.55e-05	0.000647	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—TPR—thyroid cancer	3.51e-05	0.00064	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IFNA2—thyroid cancer	3.48e-05	0.000634	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.46e-05	0.000631	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.45e-05	0.000629	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.45e-05	0.000629	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—HPGD—thyroid cancer	3.39e-05	0.000617	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.38e-05	0.000616	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—RXRA—thyroid cancer	3.34e-05	0.000609	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	3.32e-05	0.000605	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.25e-05	0.000592	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CDK1—thyroid cancer	3.23e-05	0.000588	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.16e-05	0.000576	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.11e-05	0.000567	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—HPGD—thyroid cancer	3.09e-05	0.000562	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.06e-05	0.000557	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.99e-05	0.000544	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PPARG—thyroid cancer	2.92e-05	0.000531	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.91e-05	0.00053	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—NRAS—thyroid cancer	2.87e-05	0.000523	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	2.84e-05	0.000517	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.8e-05	0.00051	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—RXRA—thyroid cancer	2.79e-05	0.000508	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.75e-05	0.0005	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.71e-05	0.000494	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.69e-05	0.000489	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.66e-05	0.000485	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.63e-05	0.000479	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—NRG1—thyroid cancer	2.59e-05	0.000472	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CHST14—thyroid cancer	2.53e-05	0.00046	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—TPR—thyroid cancer	2.51e-05	0.000458	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—RXRA—thyroid cancer	2.51e-05	0.000457	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.5e-05	0.000456	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.47e-05	0.000451	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—KRAS—thyroid cancer	2.47e-05	0.00045	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.44e-05	0.000445	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.38e-05	0.000434	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TERT—thyroid cancer	2.33e-05	0.000424	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.32e-05	0.000423	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTGS2—thyroid cancer	2.29e-05	0.000418	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PPARG—thyroid cancer	2.24e-05	0.000408	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HIF1A—thyroid cancer	2.22e-05	0.000405	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—RXRA—thyroid cancer	2.21e-05	0.000402	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—thyroid cancer	2.2e-05	0.0004	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—TPR—thyroid cancer	2.17e-05	0.000395	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PRKAR1A—thyroid cancer	2.13e-05	0.000388	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PPARG—thyroid cancer	2.11e-05	0.000384	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—HRAS—thyroid cancer	2.1e-05	0.000383	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—HPGD—thyroid cancer	2.04e-05	0.000371	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTEN—thyroid cancer	2e-05	0.000365	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—TPR—thyroid cancer	1.94e-05	0.000354	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.93e-05	0.000352	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.91e-05	0.000349	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.88e-05	0.000343	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—AKT1—thyroid cancer	1.85e-05	0.000338	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—BRAF—thyroid cancer	1.84e-05	0.000336	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—TPR—thyroid cancer	1.77e-05	0.000323	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTGS2—thyroid cancer	1.76e-05	0.000321	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.76e-05	0.000321	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.74e-05	0.000318	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.73e-05	0.000316	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTGS2—thyroid cancer	1.66e-05	0.000302	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.63e-05	0.000296	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—SLC5A5—thyroid cancer	1.62e-05	0.000295	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PPARG—thyroid cancer	1.58e-05	0.000289	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—RXRA—thyroid cancer	1.58e-05	0.000288	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.58e-05	0.000288	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.54e-05	0.00028	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.52e-05	0.000277	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000274	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTGS2—thyroid cancer	1.49e-05	0.000271	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.46e-05	0.000265	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTEN—thyroid cancer	1.45e-05	0.000264	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000254	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.38e-05	0.000252	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.36e-05	0.000249	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—RXRA—thyroid cancer	1.36e-05	0.000248	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.33e-05	0.000242	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.32e-05	0.000241	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—NRAS—thyroid cancer	1.3e-05	0.000237	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTEN—thyroid cancer	1.3e-05	0.000236	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTGS2—thyroid cancer	1.25e-05	0.000227	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.24e-05	0.000227	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—RXRA—thyroid cancer	1.22e-05	0.000223	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.21e-05	0.00022	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.19e-05	0.000217	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.18e-05	0.000216	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—TPR—thyroid cancer	1.17e-05	0.000213	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—NRAS—thyroid cancer	1.16e-05	0.000211	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—AKT1—thyroid cancer	1.15e-05	0.00021	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.15e-05	0.00021	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—KRAS—thyroid cancer	1.12e-05	0.000204	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—RXRA—thyroid cancer	1.12e-05	0.000203	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTGS2—thyroid cancer	1.1e-05	0.0002	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTEN—thyroid cancer	1.09e-05	0.000198	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.08e-05	0.000198	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.03e-05	0.000188	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PPARG—thyroid cancer	9.99e-06	0.000182	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—KRAS—thyroid cancer	9.96e-06	0.000182	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—thyroid cancer	9.93e-06	0.000181	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTEN—thyroid cancer	9.56e-06	0.000174	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—HRAS—thyroid cancer	9.5e-06	0.000173	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—AKT1—thyroid cancer	8.86e-06	0.000161	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	8.75e-06	0.000159	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PPARG—thyroid cancer	8.6e-06	0.000157	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HRAS—thyroid cancer	8.47e-06	0.000154	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—AKT1—thyroid cancer	8.39e-06	0.000153	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—AKT1—thyroid cancer	8.34e-06	0.000152	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTGS2—thyroid cancer	7.86e-06	0.000143	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PPARG—thyroid cancer	7.72e-06	0.000141	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—AKT1—thyroid cancer	7.48e-06	0.000136	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—RXRA—thyroid cancer	7.35e-06	0.000134	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PPARG—thyroid cancer	7.04e-06	0.000128	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—AKT1—thyroid cancer	6.96e-06	0.000127	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTEN—thyroid cancer	6.85e-06	0.000125	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTGS2—thyroid cancer	6.77e-06	0.000123	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—AKT1—thyroid cancer	6.26e-06	0.000114	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTGS2—thyroid cancer	6.07e-06	0.000111	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—AKT1—thyroid cancer	5.95e-06	0.000108	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTEN—thyroid cancer	5.9e-06	0.000108	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.54e-06	0.000101	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—AKT1—thyroid cancer	5.51e-06	0.0001	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTEN—thyroid cancer	5.3e-06	9.65e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTEN—thyroid cancer	4.83e-06	8.8e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PPARG—thyroid cancer	4.64e-06	8.46e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—AKT1—thyroid cancer	3.95e-06	7.19e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.65e-06	6.66e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—AKT1—thyroid cancer	3.4e-06	6.2e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTEN—thyroid cancer	3.19e-06	5.8e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—AKT1—thyroid cancer	3.05e-06	5.56e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—AKT1—thyroid cancer	2.78e-06	5.07e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—AKT1—thyroid cancer	1.84e-06	3.34e-05	CbGpPWpGaD
